destiny-breast04: exploring t-dxd and io combinations in her2-low breast cancer
Published 4 weeks ago • 27 plays • Length 1:14Download video MP4
Download video MP3
Similar videos
-
0:56
destiny-breast04: t-dxd for patients with her2-low mbc
-
5:11
destiny-breast04: t-dxd provides significant improvement in os pfs in her2-low mbc
-
2:01
destiny-breast04: practice-changing results for her2-low breast cancer
-
1:08
destiny-breast04: a ground-breaking trial in her2-low breast cancer
-
1:32
destiny-breast15: t-dxd in patients with hr hr- and her2-low or her2 ihc 0 metastatic breast cancer
-
4:15
debbrah: t-dxd in her2 or her2-low advanced breast cancer with cns involvement
-
2:05
latest news in her2-low breast cancer
-
2:30
patient-reported outcomes from destiny-breast04
-
1:09
the exciting new field of her2-low breast cancer
-
1:46
choosing between tucatinib and t-dxd in her2 breast cancer
-
1:28
destiny breast 04 data and how it impacts the current pathology landscape
-
1:16
her2climb-04: tucatinib plus t-dxd for her2 breast cancer
-
1:08
destiny-breast02: t-dxd in her2 metastatic breast cancer previously treated with t-dm1
-
1:08
updated survival results of destiny-breast03: t-dxd vs t-dm1 in her2 metastatic breast cancer
-
5:02
reflections on the destiny-breast04 trial | patricia lorusso
-
4:01
trastuzumab deruxtecan: a promising agent for treating her2-low breast cancer?
-
1:34
destiny-gastric03: t-dxd in her2 and her2-low gastric cancer
-
5:57
phase 3 study shows her2 therapy clinically meaningful for metastatic breast cancer patients
-
0:32
highlights in her2-low breast cancer at sabcs 2022